0000950170-24-079561.txt : 20240701 0000950170-24-079561.hdr.sgml : 20240701 20240701160010 ACCESSION NUMBER: 0000950170-24-079561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240627 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Shu-Chih CENTRAL INDEX KEY: 0001552127 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 241090418 MAIL ADDRESS: STREET 1: C/O ATOSSA GENETICS, INC STREET 2: 4105 E MADISON STREET, SUITE 320 CITY: SEATTLE STATE: WA ZIP: 98112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 ownership.xml 4 X0508 4 2024-06-27 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001552127 Chen Shu-Chih C/O ATOSSA THERAPEUTICS, INC., 107 SPRING STREET SEATTLE WA 98104 true false false false false Stock Option (right to buy) 1.05 2024-06-27 4 A false 125000 0.00 A 2034-06-27 Common Stock 125000 125000 D The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024. /s/ Shu-Chih Chen 2024-07-01